Creo Medical Group Plc

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00BZ1BLL44
GBP
0.12
-0.02 (-13.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Tristel Plc
Avon Protection Plc
EKF Diagnostics Holdings Plc
Smith & Nephew plc
Inspecs Group Plc
Convatec Group Plc
Creo Medical Group Plc
Advanced Medical Solutions Group Plc
Inspiration Healthcare Group Plc
Belluscura Plc
Tissue Regenix Group Plc

Why is Creo Medical Group Plc ?

1
Poor Management Efficiency with a low ROE of 0%
  • The company has reported losses. Due to this company has reported negative ROE
2
Poor long term growth as Operating profit has grown by an annual rate -5.53% of over the last 5 years
3
Flat results in Jun 25
  • RAW MATERIAL COST(Y) Grown by 39.54% (YoY)
4
With ROE of 7.55%, it has a expensive valuation with a 0.97 Price to Book Value
  • Over the past year, while the stock has generated a return of -5.23%, its profits have risen by 121.2% ; the PEG ratio of the company is 0.1
5
Underperformed the market in the last 1 year
  • Even though the market (FTSE 100) has generated returns of 15.58% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -5.23% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Creo Medical Group Plc for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Creo Medical Group Plc
-8.2%
-1.19
55.89%
FTSE 100
13.98%
1.15
13.60%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
79.03%
EBIT Growth (5y)
-5.53%
EBIT to Interest (avg)
-26.54
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.28
Tax Ratio
10.76%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
0.97
EV to EBIT
-1.79
EV to EBITDA
-1.98
EV to Capital Employed
0.95
EV to Sales
2.44
PEG Ratio
0.11
Dividend Yield
NA
ROCE (Latest)
-53.14%
ROE (Latest)
7.55%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-1What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 39.54% (YoY

Here's what is not working for Creo Medical Group Plc

Raw Material Cost
Grown by 39.54% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales